Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 27, Issue 1, pp. 226-236
PubMed
Published By
Print ISSN
Online ISSN
History
- Received June 24, 2020
- Revision received August 17, 2020
- Accepted October 13, 2020
- Published first October 22, 2020.
Article Versions
- Previous version (October 22, 2020 - 05:09).
- Previous version (November 20, 2020 - 06:16).
- Previous version (November 30, 2020 - 05:53).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- ChongFeng Gao1,
- Luke Wisniewski1,
- Ying Liu1,
- Ben Staal1,
- Ian Beddows1,
- Dennis Plenker2,
- Mohammed Aldakkak3,
- Johnathan Hall1,
- Daniel Barnett1,
- Mirna Kheir Gouda2,
- Peter Allen4,
- Richard Drake5,
- Amer Zureikat6,
- Ying Huang7,
- Douglas Evans3,
- Aatur Singhi6,
- Randall E. Brand6,
- David A. Tuveson2,
- Susan Tsai3, and
- Brian B. Haab1,*
- 1Center for Cancer and Cell Biology, Van Andel Institute, Grand Rapids, Michigan.
- 2Lustgarten Foundation Pancreatic Cancer Research Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
- 3Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.
- 4Division of Surgical Oncology, Duke University School of Medicine, Durham, North Carolina.
- 5Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina.
- 6Division of Gastrointestinal Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
- 7Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center, Seattle, Washington.
- ↵*Corresponding Author:
Brian B. Haab, Van Andel Institute, 333 Bostwick NE, Grand Rapids, MI 49503. Phone: 616-234-5268; Fax: 616-234-5269; E-mail: brian.haab{at}vai.org
January 2021
Volume 27, Issue 1
Volume 27, Issue 1
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
Jump to section
Advertisement